Welcome to the November 2018 edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. 340B INDUSTRY NEWS Read below for recent news from 340B Health. MEDICARE 340B CUTS WILL CONTINUE AND EXPAND IN 2019 Medicare cuts of nearly 30 percent… Read more »
-
-
Spreading Gratitude
Our team is honored to serve and support your organization. Thank you for the opportunity to partner alongside you as your strive for program compliance while serving your community. May you and your family have a wonderful Thanksgiving holiday. With Gratitude, The RxStrategies Team
-
Maximize 340B Program Results
RxStrategies prides itself on offering intuitive contract pharmacy management through advanced reporting and analytics. Our conservative approach to 340B maximizes program results by ensuring more of the 340B savings remain with Covered Entity (CE) through a simple, all-inclusive fee. Another way our contract pharmacy solution is able to maximize results is through our audit-proven eligibility… Read more »
-
Ready for Some Midyear Magic
The RxStrategies team is ready for some midyear magic at the ASHP Midyear Conference being held December 2-6. At this prestigious conference – the largest global gathering of pharmacy professionals – RxStrategies team members Skip Devanny, Rhodie Smith and Jonathan Ghenn will network with more than 25,000 pharmacy professionals and discuss current trends, news and… Read more »
-
Clinical Insights: November 7, 2018
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval Lorbrena® (lorlatinib) – New Drug Approval – November 2, 2018 – The Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with… Read more »
-
Clinical Insights: October 10, 2018
Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. New Drug Approval TegsediTM (inotersen) – October 5, 2018 – Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., announced that the U.S. Food and Drug… Read more »
-
Connect with Us at the 2018 HMA CFO Forum
RxStrategies’ team members, Fenton Markevich, Tim Vroman and Skip Devanny, are preparing to leave for the 2018 Health Management Academy (HMA) CFO Forum October 17-21! Chief Financial Officers from the largest health systems attend to network and discuss challenges and opportunities they face in their facilities. Our team is excited to connect with you! Learn… Read more »
-
Compliance and Connections
The 3rd Annual Council of Pharmacy Executives and Suppliers (CPES) Meeting is taking place October 3-4 in Franklin, TN. Members of the RxStrategies team will be in attendance, making connections with hospital pharmacy leaders from across the nation while discussing the latest trends impacting the pharmacy industry and strategies to maintain program compliance. The following team… Read more »
-
Proud Sponsor of APHCA’s Annual Conference
RxStrategies is a proud Platinum Presenting Sponsor of Alabama Primary Health Care Association’s (APHCA) 33rd Annual Conference and Trade Show. October 2-4 in Orange Beach, AL, members, partners and collaborators will join together to network and gain insight into leadership, management and compliance strategies. Visit booth #1 at the conference to discuss intuitive 340B solutions with… Read more »
-
Networking at the HCP 2018 Fall Hospital Pharmacy Conference
Justin Rolling and Krista Scanlon are ready for the HCP 2018 Fall Hospital Pharmacy Conference in Los Angeles, CA on October 1-3. Our team members are excited for the opportunity to network with the country’s most prestigious hospitals and health systems and other key decision makers as they gather for the Reverse Expo sessions. Learn… Read more »